Hypertension Management
Introduction to Hydralazine
- The American Heart Association and American College of Cardiology recommend that hydralazine be used with caution, as it can cause reflex tachycardia and has a variable response, with effects lasting 2-4 hours after administration, and blood pressure beginning to decrease within 10-30 minutes 1, 2
Combination Therapy
- The American Heart Association recommends combining hydralazine with isosorbide dinitrate in heart failure patients, particularly African Americans with NYHA class III-IV heart failure with reduced ejection fraction on optimal medical therapy, as an alternative to first-line agents 3, 4
First-line Alternatives
- The American Heart Association and American College of Cardiology recommend using ACE inhibitors, ARBs, beta-blockers, or calcium channel blockers as preferred agents for hypertension management, due to their safer profile and more predictable response compared to hydralazine 4
Reserve Hydralazine for
- The American College of Cardiology suggests reserving hydralazine for patients who cannot tolerate first-line agents, African American patients with heart failure when combined with isosorbide dinitrate, or as part of combination therapy when other options have failed, due to its potential for adverse effects and unpredictable response 4, 5
Dosing and Monitoring Considerations
- The American Heart Association and American College of Cardiology recommend starting with lower doses and titrating slowly if hydralazine must be used, considering combining with a beta-blocker to mitigate reflex tachycardia, and requiring more frequent follow-up when using hydralazine in patients with chronic kidney disease or acute kidney injury 1, 2, 6
- The American College of Cardiology recommends considering dose reduction in moderate to severe acute kidney injury when using hydralazine, and increasing the dosing interval rather than completely discontinuing hydralazine to minimize the risk of drug accumulation 2
Alternatives in Special Populations
- In patients with acute kidney injury, alternatives to hydralazine include calcium channel blockers (e.g., nicardipine or clevidipine), short-acting beta blockers (e.g., esmolol), and labetalol, which offer predictable effects and minimal renal effects 2
- After TEVAR, preferred agents for acute hypertension management include Calcium Channel Blockers (e.g., Nicardipine and Clevidipine), Beta-Blockers (e.g., Esmolol and Labetalol), and Nitric Oxide-Dependent Vasodilators (e.g., Sodium nitroprusside), with specific dosing recommendations and frequent blood pressure monitoring essential for precise control 7, 8
Adverse Effects and Limitations
- Hydralazine can cause reflex tachycardia, unpredictable hypotensive episodes, gastrointestinal complaints, and headaches as common adverse effects, leading to poor medication adherence if continued long-term, and is not recommended as a first-line agent for managing hypertension after TEVAR due to its unpredictable response and potential for adverse effects 5, 7, 8, 9, 1